Imprimer

Raltegravir potassium salt ≥98%, solide cristallin

Marques : Cayman Chemical
Ratings: Ecrire un avis

Total Evaluation: 0
Moyenne des Notes : 0.0 sur 5

Danger

Synonyme(s): Raltegravir potassium, Potassium 4-((4-fluorobenzyl)carbamoyl)-1-methyl-2-(2-(5-methyl-1,3,4-oxadiazole-2-carboxamido)propan-2-yl)-6-oxo-1,6-dihydropyrimidin-5-olate

16071-10 16071-1 16071-50 16071-5
CAYM16071-10EA 377 EUR
CAYM16071-10 CAYM16071-1 CAYM16071-50 CAYM16071-5
Raltegravir potassium salt ≥98%, solide cristallin
Raltegravir potassium salt

Raltegravir is a potent, selective, and orally bioavailable inhibitor of HIV integrase (IC50 = 15 nM).


It is metabolised primarily by uridine diphosphate glucuronosyltransferase 1A1. Raltegravir has long-term efficacy and safety in managing HIV-1 infection in adults, children, and adolescents.

Formule: C₂₀H₂₀FKN₆O₅
Poids moléculaire: 482.51 g/mol
Température de stockage: Réfrigérateur
Numéro MDL: MFCD12031642
Numéro CAS: 871038-72-1

Commander maintenant

Résultats des tests de spécification

Purity ≥98%
λmax 210, 312 nm


Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Plus About VWR